Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Music therapy effect on the median effective dose of remimazolam for loss of consciousness in women undergoing hysteroscopic gynecologic surgery
ChiCTR2400086458Phase 4Not yet recruiting
- Sponsor
- Fuyang Hospital of Anhui Medical University
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam in gynaecological conditions (2 arms), sponsored by Fuyang Hospital of Anhui Medical University. Primary endpoint: Sequential results of loss of consciousness induced by remimazolam and corresponding dose. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
gynaecological conditions
Beyond the preview
Go deeper on ChiCTR2400086458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086458.